US Stock MarketDetailed Quotes

INDP Indaptus Therapeutics

Watchlist
  • 2.120
  • 0.0000.00%
Close Jul 24 16:00 ET
  • 2.200
  • +0.080+3.77%
Post 19:15 ET
18.10MMarket Cap-1197P/E (TTM)

Indaptus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-11.49%3.94M
9.84%16.38M
2.27%4.18M
19.59%4.25M
-9.67%3.5M
30.95%4.46M
92.92%14.91M
26.99%4.09M
5.48%3.55M
631.92%3.87M
Selling and administrative expenses
-8.67%2.35M
1.99%8.76M
-1.39%2.15M
4.05%2.02M
-14.74%2.01M
22.34%2.58M
64.93%8.59M
-4.34%2.18M
-27.24%1.94M
1,618.28%2.36M
-General and administrative expense
-8.67%2.35M
1.99%8.76M
-1.39%2.15M
4.05%2.02M
-14.74%2.01M
22.34%2.58M
64.93%8.59M
-4.34%2.18M
-27.24%1.94M
1,618.28%2.36M
Research and development costs
-15.36%1.59M
20.51%7.62M
6.42%2.03M
38.34%2.23M
-1.70%1.48M
44.93%1.88M
150.66%6.32M
102.39%1.91M
130.70%1.61M
285.09%1.51M
Operating profit
11.49%-3.94M
-9.84%-16.38M
-2.27%-4.18M
-19.59%-4.25M
9.67%-3.5M
-30.95%-4.46M
-92.92%-14.91M
-26.99%-4.09M
-5.48%-3.55M
-631.92%-3.87M
Net non-operating interest income expense
Other net income (expense)
-32.37%136.56K
62.39%955K
-58.99%176.85K
278.29%326.02K
641.15%250.2K
446.95%201.93K
588.11K
431.25K
10,321.28%86.18K
156.40%33.76K
Other non- operating income (expenses)
-32.37%136.56K
62.39%955K
-58.99%176.85K
278.29%326.02K
641.15%250.2K
446.95%201.93K
--588.11K
--431.25K
10,321.28%86.18K
156.40%33.76K
Income before tax
10.50%-3.81M
-7.68%-15.42M
-9.49%-4M
-13.16%-3.92M
15.39%-3.25M
-26.39%-4.25M
-85.74%-14.32M
-13.66%-3.66M
-2.95%-3.47M
-644.07%-3.84M
Income tax
Net income
10.50%-3.81M
-7.68%-15.42M
-9.49%-4M
-13.16%-3.92M
15.39%-3.25M
-26.39%-4.25M
-85.74%-14.32M
-13.66%-3.66M
-2.95%-3.47M
-644.07%-3.84M
Net income continuous Operations
10.50%-3.81M
-7.68%-15.42M
-9.49%-4M
-13.16%-3.92M
15.39%-3.25M
-26.39%-4.25M
-85.74%-14.32M
-13.66%-3.66M
-2.95%-3.47M
-644.07%-3.84M
Minority interest income
Net income attributable to the parent company
10.50%-3.81M
-7.68%-15.42M
-9.49%-4M
-13.16%-3.92M
15.39%-3.25M
-26.39%-4.25M
-85.74%-14.32M
-13.66%-3.66M
-2.95%-3.47M
-644.07%-3.84M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
10.50%-3.81M
-7.68%-15.42M
-9.49%-4M
-13.16%-3.92M
15.39%-3.25M
-26.39%-4.25M
-85.74%-14.32M
-13.66%-3.66M
-2.95%-3.47M
-644.07%-3.84M
Basic earnings per share
11.76%-0.45
-5.78%-1.83
-6.82%-0.47
-11.90%-0.47
15.22%-0.39
-24.39%-0.51
8.47%-1.73
-12.98%-0.44
48.15%-0.42
-382.41%-0.46
Diluted earnings per share
11.76%-0.45
-5.78%-1.83
-6.82%-0.47
-11.90%-0.47
15.22%-0.39
-24.39%-0.51
8.47%-1.73
-12.98%-0.44
48.15%-0.42
-382.41%-0.46
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -11.49%3.94M9.84%16.38M2.27%4.18M19.59%4.25M-9.67%3.5M30.95%4.46M92.92%14.91M26.99%4.09M5.48%3.55M631.92%3.87M
Selling and administrative expenses -8.67%2.35M1.99%8.76M-1.39%2.15M4.05%2.02M-14.74%2.01M22.34%2.58M64.93%8.59M-4.34%2.18M-27.24%1.94M1,618.28%2.36M
-General and administrative expense -8.67%2.35M1.99%8.76M-1.39%2.15M4.05%2.02M-14.74%2.01M22.34%2.58M64.93%8.59M-4.34%2.18M-27.24%1.94M1,618.28%2.36M
Research and development costs -15.36%1.59M20.51%7.62M6.42%2.03M38.34%2.23M-1.70%1.48M44.93%1.88M150.66%6.32M102.39%1.91M130.70%1.61M285.09%1.51M
Operating profit 11.49%-3.94M-9.84%-16.38M-2.27%-4.18M-19.59%-4.25M9.67%-3.5M-30.95%-4.46M-92.92%-14.91M-26.99%-4.09M-5.48%-3.55M-631.92%-3.87M
Net non-operating interest income expense
Other net income (expense) -32.37%136.56K62.39%955K-58.99%176.85K278.29%326.02K641.15%250.2K446.95%201.93K588.11K431.25K10,321.28%86.18K156.40%33.76K
Other non- operating income (expenses) -32.37%136.56K62.39%955K-58.99%176.85K278.29%326.02K641.15%250.2K446.95%201.93K--588.11K--431.25K10,321.28%86.18K156.40%33.76K
Income before tax 10.50%-3.81M-7.68%-15.42M-9.49%-4M-13.16%-3.92M15.39%-3.25M-26.39%-4.25M-85.74%-14.32M-13.66%-3.66M-2.95%-3.47M-644.07%-3.84M
Income tax
Net income 10.50%-3.81M-7.68%-15.42M-9.49%-4M-13.16%-3.92M15.39%-3.25M-26.39%-4.25M-85.74%-14.32M-13.66%-3.66M-2.95%-3.47M-644.07%-3.84M
Net income continuous Operations 10.50%-3.81M-7.68%-15.42M-9.49%-4M-13.16%-3.92M15.39%-3.25M-26.39%-4.25M-85.74%-14.32M-13.66%-3.66M-2.95%-3.47M-644.07%-3.84M
Minority interest income
Net income attributable to the parent company 10.50%-3.81M-7.68%-15.42M-9.49%-4M-13.16%-3.92M15.39%-3.25M-26.39%-4.25M-85.74%-14.32M-13.66%-3.66M-2.95%-3.47M-644.07%-3.84M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 10.50%-3.81M-7.68%-15.42M-9.49%-4M-13.16%-3.92M15.39%-3.25M-26.39%-4.25M-85.74%-14.32M-13.66%-3.66M-2.95%-3.47M-644.07%-3.84M
Basic earnings per share 11.76%-0.45-5.78%-1.83-6.82%-0.47-11.90%-0.4715.22%-0.39-24.39%-0.518.47%-1.73-12.98%-0.4448.15%-0.42-382.41%-0.46
Diluted earnings per share 11.76%-0.45-5.78%-1.83-6.82%-0.47-11.90%-0.4715.22%-0.39-24.39%-0.518.47%-1.73-12.98%-0.4448.15%-0.42-382.41%-0.46
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg